Introduction
The sudden spike in failed sample collections for Color's pharmacogenomics testing service last week presents a critical issue that demands immediate attention and thorough analysis. As we delve into this problem, we'll employ a systematic approach to identify, validate, and address the root cause while considering both short-term fixes and long-term strategic implications.
This analysis follows a structured approach covering issue identification, hypothesis generation, validation, and solution development.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Recent changes often correlate with sudden performance shifts. Expected answer: Yes, a new collection kit was introduced two weeks ago. Impact on approach: If confirmed, we'd focus on the new kit's design and user instructions.
Why it matters: Understanding the exact definition helps pinpoint where in the process the failure occurs. Expected answer: Samples are considered failed if they don't meet volume or quality standards upon arrival at the lab. Impact on approach: This would guide us to look at either collection issues or transportation problems.
Why it matters: The scale of the problem influences the urgency and scope of our response. Expected answer: Normal rate is 2%, we're now seeing 15%. Impact on approach: A significant increase would suggest a systemic issue rather than random fluctuations.
Why it matters: Segmentation can reveal whether the issue is universal or specific to certain users. Expected answer: The spike is more pronounced in first-time users over 60. Impact on approach: This would lead us to investigate factors specific to this demographic, such as kit usability for older adults.
Practice similar questions
Subscribe to access the full answer